Original Article
Assessment of the Efficacy and Safety of a Combination of 2 Topical Retinoids (RetinSphere) in Maintaining Post-Treatment Response of Acne to Oral Isotretinoin
Eficacia y seguridad del uso combinado de 2 retinoides tópicos (Retinsphere®) para el mantenimiento de la respuesta obtenida tras el tratamiento con isotretinoína oral
Read
9591
Timeswas read the article
4070
Total PDF
5521
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 116 | 8 | 124 |
| 2025 5 | 361 | 50 | 411 |
| 2025 4 | 394 | 54 | 448 |
| 2025 3 | 328 | 38 | 366 |
| 2025 2 | 314 | 39 | 353 |
| 2025 1 | 193 | 37 | 230 |
| 2024 12 | 170 | 50 | 220 |
| 2024 11 | 108 | 76 | 184 |
| 2024 10 | 80 | 60 | 140 |
| 2024 9 | 99 | 35 | 134 |
| 2024 8 | 125 | 58 | 183 |
| 2024 7 | 82 | 49 | 131 |
| 2024 6 | 96 | 47 | 143 |
| 2024 5 | 82 | 43 | 125 |
| 2024 4 | 69 | 36 | 105 |
| 2024 3 | 56 | 39 | 95 |
| 2024 2 | 92 | 46 | 138 |
| 2024 1 | 76 | 40 | 116 |
| 2023 12 | 75 | 27 | 102 |
| 2023 11 | 54 | 35 | 89 |
| 2023 10 | 65 | 49 | 114 |
| 2023 9 | 59 | 37 | 96 |
| 2023 8 | 51 | 21 | 72 |
| 2023 7 | 50 | 60 | 110 |
| 2023 6 | 47 | 48 | 95 |
| 2023 5 | 67 | 70 | 137 |
| 2023 4 | 43 | 53 | 96 |
| 2023 3 | 62 | 58 | 120 |
| 2023 2 | 64 | 47 | 111 |
| 2023 1 | 45 | 41 | 86 |
| 2022 12 | 48 | 54 | 102 |
| 2022 11 | 35 | 37 | 72 |
| 2022 10 | 22 | 44 | 66 |
| 2022 9 | 29 | 49 | 78 |
| 2022 8 | 22 | 66 | 88 |
| 2022 7 | 20 | 57 | 77 |
| 2022 6 | 22 | 57 | 79 |
| 2022 5 | 75 | 56 | 131 |
| 2022 4 | 75 | 85 | 160 |
| 2022 3 | 94 | 108 | 202 |
| 2022 2 | 70 | 59 | 129 |
| 2022 1 | 78 | 86 | 164 |
| 2021 12 | 66 | 83 | 149 |
| 2021 11 | 49 | 91 | 140 |
| 2021 10 | 34 | 95 | 129 |
| 2021 9 | 31 | 73 | 104 |
| 2021 8 | 35 | 81 | 116 |
| 2021 7 | 29 | 70 | 99 |
| 2021 6 | 30 | 62 | 92 |
| 2021 5 | 27 | 78 | 105 |
| 2021 4 | 62 | 137 | 199 |
| 2021 3 | 80 | 33 | 113 |
| 2021 2 | 40 | 38 | 78 |
| 2021 1 | 32 | 47 | 79 |
| 2020 12 | 37 | 43 | 80 |
| 2020 11 | 29 | 28 | 57 |
| 2020 10 | 34 | 36 | 70 |
| 2020 9 | 53 | 21 | 74 |
| 2020 8 | 29 | 39 | 68 |
| 2020 7 | 42 | 29 | 71 |
| 2020 6 | 35 | 34 | 69 |
| 2020 5 | 40 | 53 | 93 |
| 2020 4 | 31 | 35 | 66 |
| 2020 3 | 27 | 23 | 50 |
| 2020 2 | 2 | 15 | 17 |
| 2020 1 | 7 | 7 | 14 |
| 2019 12 | 8 | 12 | 20 |
| 2019 11 | 4 | 10 | 14 |
| 2019 10 | 0 | 10 | 10 |
| 2019 9 | 0 | 17 | 17 |
| 2019 8 | 4 | 6 | 10 |
| 2019 7 | 8 | 15 | 23 |
| 2019 6 | 4 | 24 | 28 |
| 2019 5 | 6 | 23 | 29 |
| 2019 4 | 2 | 25 | 27 |
| 2019 3 | 2 | 9 | 11 |
| 2019 2 | 2 | 3 | 5 |
| 2019 1 | 2 | 2 | 4 |
| 2018 12 | 2 | 5 | 7 |
| 2018 11 | 4 | 7 | 11 |
| 2018 10 | 2 | 0 | 2 |
| 2018 9 | 5 | 4 | 9 |
| 2018 8 | 0 | 12 | 12 |
| 2018 7 | 0 | 11 | 11 |
| 2018 6 | 0 | 5 | 5 |
| 2018 5 | 0 | 5 | 5 |
| 2018 4 | 0 | 10 | 10 |
| 2018 3 | 1 | 2 | 3 |
| 2018 2 | 17 | 4 | 21 |
| 2018 1 | 21 | 6 | 27 |
| 2017 12 | 26 | 17 | 43 |
| 2017 11 | 22 | 6 | 28 |
| 2017 10 | 18 | 21 | 39 |
| 2017 9 | 10 | 15 | 25 |
| 2017 8 | 26 | 13 | 39 |
| 2017 7 | 14 | 15 | 29 |
| 2017 6 | 22 | 22 | 44 |
| 2017 5 | 26 | 20 | 46 |
| 2017 4 | 19 | 16 | 35 |
| 2017 3 | 10 | 81 | 91 |
| 2017 2 | 24 | 34 | 58 |
| 2017 1 | 14 | 31 | 45 |
| 2016 12 | 18 | 24 | 42 |
| 2016 11 | 22 | 25 | 47 |
| 2016 10 | 23 | 21 | 44 |
| 2016 9 | 0 | 10 | 10 |
| 2016 8 | 0 | 7 | 7 |
| 2016 7 | 9 | 3 | 12 |
| 2016 6 | 14 | 12 | 26 |
| 2016 5 | 15 | 16 | 31 |
| 2016 4 | 18 | 11 | 29 |
| 2016 3 | 11 | 11 | 22 |
| 2016 2 | 10 | 10 | 20 |
| 2016 1 | 13 | 3 | 16 |
| 2015 12 | 9 | 7 | 16 |
| 2015 11 | 10 | 0 | 10 |
| 2015 10 | 5 | 8 | 13 |
| 2015 9 | 5 | 4 | 9 |
| 2015 8 | 0 | 3 | 3 |
| 2015 7 | 3 | 6 | 9 |
| 2015 6 | 6 | 1 | 7 |
| 2015 5 | 6 | 3 | 9 |
| 2015 4 | 2 | 3 | 5 |
| 2015 3 | 3 | 4 | 7 |
Show all
